| Mitogens | Kv1.3 blockers (Concentration) | Viability (%) | |
| Control | Stress | ||
| None | None | 91.3 ± 2.1 | 96.9 ± 0.6 |
| Con A | None | 94.8 ± 0.3 | 83.2 ± 0.5 |
| Quinine (4.0 × 10−5 M) | 90.3 ± 1.4 | 87.3 ± 3.4 | |
| 4-AP (4.0 × 10−3 M) | 90.8 ± 0.0 | 87.2 ± 1.7 | |
| TEA (1.0 × 10−2 M) | 94.3 ± 0.6 | 85.4 ± 1.3 | |
| TMA (4.0 × 10−2 M) | 93.2 ± 1.1 | 83.5 ± 2.6 | |
| LPS | None | 83.4 ± 1.3 | 89.4 ± 2.0 |
| Quinine (4.0 × 10−5 M) | 92.8 ± 1.4 | 83.8 ± 0.9 | |
| 4-AP (4.0 × 10−3 M) | 94.0 ± 1.8 | 84.8 ± 1.3 | |
| TEA (1.6 × 10−2 M) | 91.2 ± 2.0 | 84.0 ± 1.0 | |
| TMA (1.6 × 10−2 M) | 92.3 ± 1.5 | 87.7 ± 1.3 | |